Close

Clinical Trials

FDA New Rules For Broader Representation In Drug Testing

The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors can develop Diversity Action Plans to ensure trial participants better reflect the populations that will...

US Clinical Trials Supply & Logistics Market: A Growth Story

As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023 and, in another 10 years, will hit $3.95 billion, thereby growing at an impressive CAGR...

Data from the first human study demonstrate excellent performance of Zerion Pharmas Dispersome technology

Zerion Pharma A/S announces positive results from the first human clinical study of a Dispersome® formulation of the drug Ivacaftor, a pharmaceutical used to treat cystic fibrosis. The study was conducted by ZERION’s Spanish partner Insud Pharma, a global...

Can Clinical Research Spectrum Make The Most of Gene Therapy

It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first approval when it comes to gene therapy in 2017, oncology researchers have gone on to...

Patient Verification Tools Worked Upon For Clinical Trials

Verified Clinical Trials is all set to integrate its research participation verification tools with the clinical trial automation platform of ProofPilot in a new strategic partnership, the trial solution providers went on to announce on March 19. It is...

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches with a pioneering approach that addresses two of the most strategic challenges in the biopharma industry today - incorporating multiple outcomes that matter to patients into a...

PharmaLinea’s UTI Free Sachets clinically shown to improve standard antibiotic therapy and resolve the crucial issue of recurrence

In light of the upcoming International Women’s Day, PharmaLinea has announced the publication of a new clinical study, addressing one of the most pressing global health issues for women – recurring urinary tract infections (UTIs). UTIs are highly prevalent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read